Invitation to Vimian’s year-end report for 2022

News
Feb 24 2023

Invitation to Vimian’s year-end report for 2022

Vimian Group AB will publish its year-end report for 2022 on Wednesday, 8 March 2023, at 07.45 (CET). An audiocast will be organised for investors, analysts and media, on the same day at 09.00 (CET).

CEO, Fredrik Ullman and CFO, Carl-Johan Zetterberg Boudrie from Vimian will present and comment on the year-end report. The audiocast will be held in English and include a question-and-answer session.

To attend the telephone conference:
Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. Questions can be asked verbally via the telephone conference.
https://conference.financialhearings.com/teleconference/?id=5002947

To attend the webcast:
Link: https://ir.financialhearings.com/vimian-group-q4-2022

Related presentation materials will be available on Vimian’s website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 700 people and have a combined annual turnover of approximately EUR 170 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, info@fnca.se. For more information, please visit: www.vimian.com.